اساتید - دانشکده مدیریت و اطلاع رسانی پزشکی

درباره

رزومه

کتاب ها

عنوان کتاب : مبانی ارزیابی های اقتصادی در سلامت

نویسندگان : علی ایمانی , علی جنتی مینا گلستانی

مترجم :

انتشارات :

تاریخ چاپ :

راهنمایی و مشاوره پایان نامه

اختراعات

مشاهده برنامه حضور فیزیکی

مقالات ارائه شده

مقالات چاپ شده در مجلات

عنوان مقاله : Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran

نویسنده رابط : علی ایمانی

عنوان مجله و شماره مجله : Clinicoecon Outcomes Res

نویسندگان : Hamid Reza Rasekh, Ali Imani, Mehran Karimi, and Mina Golestani

سال انتشار : 2011

چکیده : Abstract Background In developing countries, the treatment of hemophilia patients with inhibitors is presently the most challenging and serious issue in hemophilia management, direct costs of clotting factor concentrates accounting for >98% of the highest economic burden absorbed for the health care of patients in this setting. In the setting of chronic diseases, cost-utility analysis, which takes into account the beneficial effects of a given treatment/health care intervention in terms of health-related quality of life, is likely to be the most appropriate approach. Objective The aim of this study was to assess the incremental cost-effectiveness ratios of immune tolerance induction (ITI) therapy with plasma-derived factor VIII concentrates versus on-demand treatment with recombinant-activated FVIIa (rFVIIa) in hemophilia A with high titer inhibitors from an Iranian Ministry of Health perspective. Methods This study was based on the study of Knight et al, which evaluated the cost- effectiveness ratios of different treatments for hemophilia A with high-responding inhibitors. To adapt Knight et al’s results to the Iranian context, a few clinical parameters were varied, and cost data were replaced with the corresponding Iranian estimates of resource use. The time horizon of the analysis was 10 years. One-way sensitivity analyses were performed, varying the cost of the clotting factor, the drug dose, and the administration frequency, to test the robustness of the analysis. Results Comparison of the incremental cost-effectiveness ratios between the three ITI protocols and the on-demand regimen with rFVIIa shows that all three ITI protocols dominate the on-demand regimen with rFVIIa. Between the ITI protocols the low-dose ITI protocol dominates both the Bonn ITI protocol and the Malmö ITI protocol and would be the preferred ITI protocol. All of the three ITI protocols dominate the on-demand strategy, as they have both a lower average lifetime cost and higher quality-adjusted life-years (QALYs) gained. The cost per QALY gained for the Bonn ITI protocol compared with the Malmö ITI protocol was $249,391.84. The cost per QALY gained for the Bonn ITI protocol compared with the low-dose ITI protocol was $842,307.69. Conclusion The results of data derived from our study suggest that the low-dose ITI protocol may be a less expensive and/or more cost-effective option compared with on-demand first-line treatment with rFVIIa. Keywords: cost-utility analysis, immune tolerance induction, on-demand, rFVIIa

دانلود

عنوان مقاله : Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran

نویسنده رابط : Koustuv Dalal

عنوان مجله و شماره مجله : BMC Neurology

نویسندگان : Ali Imani, Farid Gharibi, Ali Khezri, Nasrin Joudyian & Koustuv Dalal

سال انتشار : 2020

چکیده : Background Multiple sclerosis (MS) causes significant economic burden to the patients, families, health systems and society. This study aimed to estimate the annual economic costs incurred by patients with multiple sclerosis (pwms) at different levels of the disease. Method This was a cross-sectional study, using the Expanded Disability Status Scale (EDSS) tool for assessing the disease level of 300 (=N) pwms in East Azerbaijan province, Iran. To estimate the cost of MS, a questionnaire with its validity and reliability (CVR 92% and CVI 87%) and pilot test (Cronbach’s alpha score 0.89) was used. The data were collected by interviewing pwms and reviewing their clinical records. Multivariate linear regression was used to assess the relationship between disease levels and incurred costs. Results The results revealed that the mean annual cost for pwms in Iran is 97,521,740 IRR (equivalent to 2321.94 USD; 1978.93 EURO) and the mean score of EDSS in pwms was 3.14. The annual cost incurred by pwms with mild, moderate and severe levels of disease were 83,918,150 IRR (1998.05 USD; 1702.88EURO), 137,772,660 IRR (3280.30 USD; 2795.71 EURO) and 119,962,670 IRR (2856.25 USD;2434.30 EURO), respectively. Also, on average, each increase in EDSS score in pwms in Iran led to increase 8,139,260 IRR (equivalent to 193.79 USD; and 165.16 EURO) in total annual cost which must paid from pwms and their households exclusively. Also, there was a significant relationship between total annual cost and disease severity in such a way that any increase in EDSS degree is led to 8,139,260 IRR (193.79 USD; 165.16 EURO) added cost for pwms. Conclusion The study results could be helpful for Iranian health managers to solve problems which are facing by the patients with multiple sclerosis and their families.

دانلود

عنوان مقاله : Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran

نویسنده رابط : Ali Jannati

عنوان مجله و شماره مجله : Value in Health

نویسندگان : JavadGhoddoosiNejad,AliJannati,LeilaDoshmangir,MortezaArabZozani,AliImani

سال انتشار : 2019

چکیده : Objective To understand the stewardship challenges in strategic purchasing of health care in Iran's health system from the viewpoints of experts, policy makers, and decision makers. Study design This was a qualitative study. Methods Researchers used interviews and FGDs for collecting and framework analysis for analyzing data. Results Stewardship challenges were classified into three themes and nine subthemes. A lack of management information systems, a lack of enforcement for rules and laws, a lack of stewardship units, and the conflict of interest between the Ministry of Health and insurers as care purchasers in the health system are among the main challenges identified in the implementation of the strategic purchasing of health care in Iran. Conclusion A strong stewardship is needed for implementing strategic purchasing of health care, which requires participation of all stakeholders.

دانلود

عنوان مقاله : Affecting medical equipment maintenance management: A systematic review

نویسنده رابط : Ali Imani

عنوان مجله و شماره مجله : Journal of Clinical and Diagnostic Research

نویسندگان : Bahreini, R.a, Doshmangir, L.b, Imani, A.c

سال انتشار : 2018

چکیده : Introduction: The medical equipment maintenance management is a pivotal issue for the safety and cost of medical devices in order to improve medical devices system targets. We need a comprehensive assessment tool that covers all aspects of medical equipment maintenance management in hospitals. In this regard, identification of influential factors is essential. Aim: The aim of the present systematic review was to extract the factors affecting the medical equipment maintenance management. Materials and Methods: We conducted a comprehensive search in databases including OVID, PubMed, ProQuest, Scopus, Embase, Science Direct and web of science without any time limitation until October 2015. The result was updated in June 2017. Inclusion criteria were all studies related to medical equipment maintenance management and mentioning at least one factor that affects this process. Two independent reviewers checked the research process, screening of articles and quality assessment. Quality of the studies was assessed by QASP and STROBE checklist. Results: A total of 29 articles were included in this study. All the included articles were in English language. Finally, 89 factors were identified that affect the medical equipment maintenance management. Five of the factors were found related to resources item, 12 factors related to service, four factors related to education, 15 of these factors regarding to quality control, 19 factors related to inspection, 12 factors related to information bank and 22 factors was dedicated to management. Conclusion: Influential factors (management, resources, information bank, inspection, quality control, education and service) are implicated in decision-making in support of selection, purchase, repair and maintenance of medical equipment, especially for capital equipment managers and medical engineers in hospitals and also for assessment of this process. Identification and classification of influential factors can be of help for raising critical alerts about equipments more prone to maintenance problems. © 2018, Journal of Clinical and Diagnostic Research. All rights reserved.

دانلود

عنوان مقاله : Cost-effectiveness analysis of biogeneric recombinant activated factor VII (AryoSeven™) and activated prothrombin complex concentrates (FEIBA™) to treat hemophilia a patients with inhibitors in Iran

نویسنده رابط : Peyman Eshghi

عنوان مجله و شماره مجله : Iran J Pharm Res. 2016 Spring; 15(2): 669–677.

نویسندگان : Mina Golestani et al

سال انتشار : 2016

چکیده : Nowadays, bypassing agents such as recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC) are used to treat bleeding episodes in the Hemophilia patients with inhibitors. AryoSeven® is an Iranian biogeneric rFVIIa with homogeneity of efficacy and the nature to NovoSeven in a comparative trial. The current clinical trial aimed to evaluate the cost-effectiveness of FEIBA and AryoSeven® by Decision Analytic Model according to the Iranian healthcare system. An open label, multi-center, cross-over clinical trial was designed. Patients were categorized into 3 groups based on their prior tendency to one or none of the products. To determine the premium therapeutic strategy, the Incremental cost-effectiveness ratio (ICER) was calculated. Protocol F led to more treatment success in group F than the other groups (P= 0.03). Also, there was a significant statistical difference between the mean of effectiveness scores in the groups using protocol F (P = 0.01). The effectiveness of protocol F and A were 89% and 72%, respectively. ICER cost US$ to manage an episode of bleeding to get one more unit of effectiveness using FEIBA VS. AryoSeven. Although the results showed that AryoSeven was more cost-effective compared to FEIBA, the two strategies were undominated. In other words, both medicines can be applied in the first line of the treatment if the cost of FEIBA was reduced. The present clinical trial was registered at IRCT website, under ID No.2013020612380N1. Key Words: AryoSeven, Cost-effectiveness, FEIBA, Hemophilia A, Inhibitor

دانلود

عنوان مقاله : Identification of indicators for evaluating the financial and economic performance of the pharmacy: A systematic review

نویسنده رابط : Mona Moghimi

عنوان مجله و شماره مجله : Pharm Sci. 2015;21(2): 111-124.

نویسندگان : Ali Imani , Ali Janati , Mona Moghimi *, Mina Golestani , Leila Doshmangir

سال انتشار : 2015

چکیده : Nowadays, by the increasing of the pharmaceutical expenditure the health system in all countries has gone under pressure. Thus, a process must be provided to assess the financial performance of this industry as it is essential to ensure that the limited resources are spent for the best advantages. Objectives: This study aimed to review indicators for evaluating the economic and financial performance of pharmacies. Methods: A systematic literature research was conducted using seven different search engines and electronic databases (PubMed, EBESCO, Ovid, ProQuest, springer, Science Direct, Scopus) until March 2014 without any time limitation. Inclusion criteria were: articles published in English, and the studies that focused on financial or economical scopes of pharmacy services. Studies that evaluated only clinical or humanistic performance of the pharmacy without an economic and financial assessment and also studies presented in seminars or conferences and letter to editor were excluded from the study. Selected studies were examined carefully, and their results were summarized via Extraction Table. Results: finally, 15 articles were chosen from 1437 articles. After assessment of articles, 108 financial and economic indicators selected for evaluating pharmacy’s performance. Some indicators were: current ratio, cash ratio, total asset turnover, Net Profit Percentage (NPP). Finally, the financial and economic indicators were divided into three scopes: input, process and output indicators. Conclusion: for evaluating pharmacy’s performance, valid financial and economic indicators are required. The financial and economic indicators which had been summarized and sorted in our study can be applied by any country for codifying their local indicators. Keywords: Indicator, Financial, Economic, Performance, Pharmacy

دانلود

عنوان مقاله : Evaluation of factors affecting sales of prescription medicines by econometric methods in Iran

نویسنده رابط : Ali Imani

عنوان مجله و شماره مجله : Pharm Sci. 2013;19(3): 101-107.

نویسندگان : Abbas Kebriaee Zadeh, Nima Tahmasebi, Ali Imani*, Mina Golestani

سال انتشار : 2013

چکیده : Background: There are many factors that affect the prescribing of a medication. Among them, promotion of a medication by the pharmaceutical companies, the physicians’ knowledge base, and pricing are the most important. The objective of this study was to demonstrate how these parameters affect the prescribing behavior and determine their affects on the prescription process. Methods: In order to investigate the effect of price, advertisement, and the physician gender and age on the sales and prescribing process of three medicines, namely fluvoxamine, clopidrogrel and latanoprosta the pooling data method in econometrics (Panel data) was used. Results: We found that advertisement and medical insurance coverage for the medication had a significant positive effect on prescription of all three medicines. At the same time, a negative relationship was seen between increasing price and the frequency of prescription of a medicine. The gender and age of the physician also affected the behavior of prescribing. Moreover, we found out that advertisement has a direct effect on raising the demand and prescription of all the medicines. Conclusions: Health policy makers as well as pharmaceutical companies should consider the impact of advertisement and also the age and gender of the prescriber on the prescribing frequency of a particular medicine. Keywords: Prescription Medicines, Econometrics Methods, Iran

دانلود

عنوان مقاله : Readiness for diet change and its association with diet knowledge and skills, diet decision making and diet barriers in type 2 diabetic patients

نویسنده رابط : RahimKhodayari Zarnaq

عنوان مجله و شماره مجله : Diabetes & Metabolic Syndrome: Clinical Research & Reviews

نویسندگان : HabibJalilian,Mohammad ZakaryaPezeshki,AliJanati,FarzadNajafipour,AliImani,Morteza ArabZozani,RahimKhodayari Zarnaq

سال انتشار : 2019

چکیده : Aims to investigate stages of change for dietary in type 2 diabetics and its associations with diet knowledge and skills, diet decision making and diet barriers. Materials and methods This was a cross-sectional study which was conducted on 1139 diabetics aged>18 years in East Azerbaijan, Iran. Data were collected through a Personal Diabetes Questionnaire (PDQ) and analyzed through SPSS version 22 software using descriptive statistics, Chi-square and one-way ANOVA tests. Tukey's HSD post hoc tests were applied to illustrate ANOVA findings. Results 59.3% of patients do not follow a diet plan to control their blood glucose. 44.7%, 5.5%, 13%, and 36.8% of patients, respectively, were in the stages of pre-contemplation, contemplation, preparation and action. Patients who had shorter disease duration and those whose current treatment was lifestyle change were more likely within the action stage. Also, patients who had a higher score in diet knowledge and skills and diet decision making and those who had a lower score in diet barriers were more likely in the action stage of change. Conclusion Based on the results of this study, a considerable proportion of diabetic patients were in the pre-contemplation stage. Diet knowledge and skills, diet decision making and diet barriers were factors contributing to diet readiness to change. Therefore, taking necessary measures to increase diet knowledge, skills and diet decision-making and a reduction in diet barriers can help people with type 2 diabetes to change diet.

دانلود

عنوان مقاله : Influential factors on medical equipment maintenance management: In search of a framework

نویسنده رابط : Leila Doshmangir

عنوان مجله و شماره مجله : Journal of Quality in Maintenance Engineering

نویسندگان : Rona Bahreini, Leila Doshmangir, Ali Imani

سال انتشار : 2019

چکیده : Purpose Effective maintenance management of medical equipment is one of the major issues for quality of care and cost-effectiveness especially in modern hospitals. An effective medical equipment maintenance management (MEMM) consists of adequate planning, management and implementation. This is essential for providing good health services and saving scarce resources. Considering the importance of the subject, the purpose of this paper is to extract the influential factors on MEMM using a qualitative approach. Design/methodology/approach Documents review and interviews were main methods for data collection. Semi structured interviews were conducted with a purposive sample of 14 clinical engineers with different degree of education and job levels. Interviews were voice recorded and transcribed verbatim. Qualitative data were analyzed using a content analysis approach (inductive and deductive) to identify the underlying themes and sub-themes. Findings Factors influencing an effective and efficient MEMM system categorized in seven themes and 19 sub-themes emerged. The themes included: “resources,” “quality control,” “information bank,” “education,” “service,” “inspection and preventive maintenance” and “design and implementation.” Originality/value The proposed framework provides a basis for a comprehensive and accurate assessment of medical equipment maintenance. The findings of this study could be used to improve the profitability of healthcare facilities and the reliability of medical equipment.

دانلود

عنوان مقاله : Studying international competitiveness in pharmaceutical sector in selected developed countries

نویسنده رابط : Mina Golestani

عنوان مجله و شماره مجله : https://doi.org/10.22159/ajpcr.2018.v11i3.21554

نویسندگان : SEYEDE ZEINAB MOUSAVI, SAEED RASEKHI, MINA GOLESTANI*, ALI IMANI

سال انتشار : 2018

چکیده : Objectives: Competitiveness is the ability of countries in increasing market share, profits, value added, and staying at the scene of fair and international competition for a long period of time. This is realized through market authority and establishing activities based on comparative and competitive advantages. On the other hand, the research-based pharmaceutical industry makes a major contribution to the prosperity of the world economy. It is a robust sector that has been one of the pillars of industrialized economies and is increasingly recognized as an important sector in the developing world as well. Furthermore, global sales of pharmaceutical products represent the international spread of medical technology that comes as the result of highly intensive R and D efforts in the exporting countries (International Federation of Pharmaceutical Manufacturers and Associations, 2012). The present study aimed to analyze and investigate the international competitiveness of pharmaceutical sector in selected developed countries using traditional and new indices of competitiveness. Methods: In this study, revealed comparative advantage index and also static and dynamic intra-industry trade (IIT) indices were used in the period 2000â€“2012. Results: The results indicated the growing competitiveness in most of the selected countries. Furthermore, the findings suggested that countries with higher levels of international trading of pharmaceutical goods have a higher potential of competitiveness based on IIT and comparative advantage indices. Conclusions: For increase in international competitiveness in pharmaceutical industry, selected developed countries pay attention to both comparative and competitive advantages. KEYWORDS: Competitiveness, Revealed comparative advantage, Intra-industry

دانلود

عنوان مقاله : Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran

نویسنده رابط : CHERAGHALI ABDOL MAJID

عنوان مجله و شماره مجله : IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES 2016 , Volume 12 , Number 2; Page(s) 85 To 90.

نویسندگان : GOLESTANI MINA, Eshghi Peyman, CHERAGHALI ABDOL MAJID*, Rasekh Hamid Reza, Salamzadeh Jamshid, Imani Ali

سال انتشار : 2016

چکیده : Abstract: Bypassing agents are the most commonly used medicines for the treatment of hemophilia patients with inhibitors. The aim of this study is to identify the cost components of management of bleeding vents in hemophilia patients with inhibitors in Iran. This study is a cross-sectional study using a bottom-up approach to determine the cost components of treatment of hemophilia patients with inhibitors via ascertaining of all direct medical and non-medical costs. The evaluatiion of cost components of 20 patients with 40 episodes of bleeding showed that the price of medicines used is responsible for more than 96% and 97% of costs in treatment of hemophilia patients using FEIBA® and AryoSeven, respectively. The results of this study showed that cost of treating one bleeding episode in hemophilia A patients with high antibody titer using FEIBA is 376 USD compared to 857. 3 USD for AryoSeven® . Despite the small number of hemophilia patients with inhibitor in Iran, due to high cost of treating these patients, it is very important to choose the cost-effective treatment protocol for the treatment of these patients. Keyword(s): bypassing agents,cost components,hemophilia,inhibitor

دانلود

عنوان مقاله : Assessment of healthcare providers’ performance considering three healthcare quality indicators: A review article

نویسنده رابط : JANNATI ALI

عنوان مجله و شماره مجله : SHIRAZ E MEDICAL JOURNAL MAY 2016 , Volume 17 , Number 4-5; Page(s) 0 To 0.

نویسندگان : ALMASPOOR KHANGAH HASSAN, JANNATI ALI*, IMANI ALI

سال انتشار : 2016

چکیده : Context: In many healthcare systems, the quality of the healthcare delivered is monitored using a number of “indicators.” In the present review, we investigate studies that address issues with the care delivered by healthcare providers. To do this, we employ indicators of the quality of those healthcare services. Evidence Acquisition: The studies for the review were identified by searching a number of electronic databases, including Cochrane Library, PubMed, Scopus, Ovid (Medline), the Social Sciences Citation Index, SID (Scientific Information Database, or Persian database), and Iran Medex (Persian database). Of 8, 850 studies published between January 1971 and May 2015, 53 met the study criteria and were reviewed. In this study, the following key words were searched, both alone and in combination: health, healthcare, health care, provider*, effectiveness, quality, clinical outcome, patient satisfaction, and quality of life. We also considered healthcare quality indicators such as “clinical outcome, ” “patient satisfaction, ” and “quality of life” for our assessment of the quality of healthcare providers. Results: Of the 53 papers selected, 18 assessed the quality of care provided for cardiovascular disorders, 12 studied cancer conditions, eight dealt with metabolic disorder sand diabetes, six focused on a cute infection, three assessed orthopedics and trauma conditions, two studied pediatric conditions, two assessed obstetrics and gynecology conditions, one dealt with asthma and allergic disease conditions, and one assessed geriatric conditions. In our assessment of improvements in healthcare providers’ performance based on healthcare quality indicators, improvements in clinical outcomes ranged from 26.6% for cancer conditions to 98.8% for pediatric and gynecological conditions. An acceptable level of patient satisfaction was achieved in the range of 30.2% for cancer conditions to 96.0% for pediatric conditions, while improvements to quality of life ranged from 12.5% for cancer conditions to 88.7% for acute infection. Conclusions: Taking account of three indicators for assessing the quality of healthcare providers (clinical outcome, patient satisfaction, and quality of life), the high estim provement level samong providers were observed for pediatric and gynecological conditions, and the lowest improvement levels were found for cancer conditions. Keyword(s): HEALTHCARE PROVIDERS, HEALTHCARE QUALITY, INDICATORS, REVIEW

دانلود

عنوان مقاله : Challenges of implementing strategic purchasing of health services in Iran: A qualitative study Ali

نویسنده رابط : Djavad Ghoddoosi-Nejad

عنوان مجله و شماره مجله : Acta Medica Mediterranea, 2016, 32: 1033

نویسندگان : Ali Janati, Djavad Ghoddoosi-Nejad, Leila Doshmangir, Ali Imani

سال انتشار : 2016

چکیده : Introduction: To understand the challenges of implementing strategic purchasing of health services in Iran from the viewpoints of experts, policy makers, and decision makers. Methods: In a qualitative study in 2014-15, one focus group discussion -FGD- and 21 interviewees carried out with policy makers, decision makers and experts. Experts were selected from purchaser organizations of health services in Iran health system. The content analysis method was used to analyze the data. Results: five important themes emerged after the data were analyzed, i.e., infrastructures of strategic purchasing, stakeholders of purchasing health services, payment system, package of health services, and stewardship of health system. Conclusion: along-term, well-defined plan, developed with the participation of all stakeholders, is needed for proper implementation of strategic purchasing. Key words: purchasing, health services, Iran, payment system, benefit package.

دانلود

عنوان مقاله : Comparison of bypassing agents in bleeding reduction in treatment of bleeding episodes in patients with haemophilia and inhibitors

نویسنده رابط : Eshghi, P

عنوان مجله و شماره مجله : Iranian Red Crescent Medical Journal, 2014, 16(12), e24551

نویسندگان : Golestani, M., Eshghi, P., Rasekh, H.R., ...Salamzadeh, J., Imani, A.

سال انتشار : 2014

چکیده : Evidence Acquisition: After reviewing the databases of PubMed, Scopus, MD Consult, Ovid, Trip database, Google Scholar, ProQuest and the Cochrane Library, finally, 17 papers published from 2000 to 2013 were extracted. We used as a random effect model in meta-analysis. Comprehensive meta-analysis (CMA) software was used for calculating and estimating the mean of bleeding reduction and performing meta-analysis. Results: The mean of bleeding reduction in aPCC and rFVIIa were 71.2% with CI 95% (lower limit 86.8% and upper limit 82%) and 72.3% with CI 95% (lower limit 57.6% and upper limit 83.4%), respectively. Conclusions: Although differences between the two products were very close to each other, they reported similar effects on joint bleeds. Further clinical studies should be performed by incorporating a standardized measurement in comparative efficacy of aPCC and rFVIIa. Context: Mild-to-moderate bleeding disorders in haemophilia are primarily treated via recombinant activated factor VII a (rFVIIa) or activated prothrombin complex concentrate (aPCC). However, the efficacy of each bypassing agents may vary and none of them is universally effective. © 2014, Iranian Red Crescent Medical Journal.

دانلود

عنوان مقاله : The relationship between pharmaceutical expenditures, health care expenditures and gross domestic product in Iran:1999-2008

نویسنده رابط : Imani A

عنوان مجله و شماره مجله : Pharmaceutical Sciences, 2012, Vol. 18, No 1 . , Page -9 s 18

نویسندگان : Golestani M., Rasekh H.R., Imani A

سال انتشار : 2012

چکیده : Objectives: Based on theoretical principles and experimental observations, Health expenditure and real GDP in each country has a reciprocal relationship and the effect of each of these variables on other variables regardless of their interactions in terms of econometric methods would not be very reliable. Accordingly, this study investigated the relationship between pharmaceutical expenditures, health care expenditures and GDP in Iran. Methods: The study was analytical and ecological correlation type and Partial Correlation and regression tests have been used. The variables in this study consisted of gross domestic product, total pharmaceutical expenditures, Per capita drug consumption and total health expenditures. Data needed from different sources has been collected and wereanalyzed by SPSS software.Results: In the significance level (P <0.01), variables, GDP per capita, total health expenditure and total pharmaceutical expenditures with per capita drug consumption had a statistically significant relationship. Based on study results, the variables of GDP, total health expenditure and total pharmaceutical expenditures 99.3 percent of the variance in per capita drug consumption and 99.8 percent change in total pharmaceutical expenditures can be explained. According to the results of the regression, the variable per capita health expenditures with a beta standard (β=0.759 and β=0.987) better than variable of economic growth predicted the per capita drug consumption and total pharmaceutical expenditures variables.Conclusion: In the years studied, per capita drug consumption with total health expenditure, total pharmaceutical expenditures and per capita gross domestic production was statisticaly correlated. Key words: Total pharmaceutical expenditures, Total health expenditure, GDP and Iran

دانلود

برنامه درسی ترم جدید

سوابق اجرایی

موضوع	مقام مسئول	شروع	ختم	مدت اجرا
معاون آموزشي و پژوهشي گروه	معاون	آذر 1392	آذر 1393	1 سال
قطب علمي و آموزشي مديريت سلامت ايران	معاون فني	شهريور 1392	1394	2سال
مسئول دفتر توسعه آموزش و نظام استاد مشاور دانشکده	مسئول	فروردين 1392	آذر 1393	20 ماه
معاون تحقیقات و فناوری دانشکده	معاون	آذر 1393	تاکنون
کميته منتخب دانشکده	دبیر	بهمن 1393	تاکنون

عنوان يا سمت	تاريخ		مدت
عنوان يا سمت	شروع	خاتمه	مدت
کارشناس شبکه بهداشت و درمان گرمسار	1381	1388	8 سال
کارشناس پژوهشي دفتر برنامه ريزي و منابع مالي وزارت بهداشت و درمان و آموزش پزشکي	1388	1389	1 سال
عضو هيئت علمي متعهد خدمت دانشگاه علوم پزشکي تبريز	1391	تاکنون
مسوول دفتر توسعه آموزش دانشکده مديريت و اطلاع رساني پزشکي تبريز	1392	آذر 1393
مسوول نظام استاد راهنماي دانشکده مديريت و اطلاع رساني پزشکي تبريز	1392	آذر 1393
معاون فني قطب علمي و آموزشي مديريت سلامت ايران	1392	تاکنون
عضو کميته ارزشيابي دانشگاه علوم پزشکي تبريز	1392	تاکنون
عضو شوراي پژوهشي مرکز تحقيقات مديريت خدمات بهداشتي و درماني، مرکز کشوري مديريت سلامت	1392	تاکنون
مسوول حيطه مديريت المپياد علمي دانشجويان دانشگاه علوم پزشکي تبريز 1392	1392	همان سال
عضو تيم بازنگري کوريکولوم آموزشي دوره کارشناسي رشته مديريت خدمات بهداشتي و درماني 1392	1392	همان سال
معاون آموزشي و پژوهشي گروه	1392	1393
معاون پژوهشي دانشکده	1393	تاکنون

علایق

علاقمندی های پژوهشی دکتر علی ایمانی

1.        مطالعات کمی در حوزه مدیریت و اقتصاد دارو

2.       مدیریت مالی سازمان های سلامت

3.      تحلیل هزینه و هزینه یابی خدمات سلامت

4.       محاسبه و تحلیل باربیماری ها (BOD )

5.      مدلسازی اقتصادی در سلامت(مدل های مارکف و درخت تصمیم گیری)

6.       استخراج ترجیحات بیماران و جامعه(WTP ، QoL )

7.      ارزیابی اقتصادی مداخلات بهداشتی و درمانی (تکنیک های CMA ، CEA ، CoI ، CUA ، CBA )

8.      ارزیابی فناوری سلامت (HTA )

9.       اقتصاد داروخانه

10.     اقتصاد صنعت داروسازی

11.     اقتصاد صنعت بیمارستان

12.    اقتصاد آموزش علوم پزشکی

13.   اقتصاد پژوهش، اقتصاد سالمندی

14.    پژوهش عملیاتی و کاربرد آن در نظام سلامت

15.   اقتصاد مهندسی

Research Interests:

Health Care Economics

Economic Evaluation in Health Care

Pharmacoeconomics and Outcome Research

Modelling in Health Care

Managerial Finance

Education Economics

کارگاه ها

رديف	موضوع	مدّت	مجري	شهر	سال
1	ارتقاء مستمر کيفيت	دو روزه	شبکه بهداشت و درمان گرمسار	گرمسار	1382
2	بيمه درمان و اقتصاد سلامت	يکروزه	دانشگاه تربيت مدرس	تهران	1384
3	- گذراندن دوره هاي آموزشي ICDEL	دوره آموزشي	دانشگاه علوم پزشکي سمنان	سمنان	1385
4	عدالت در سلامت با نگاهي به بودجه 87	يکروزه	سازمان نظام پزشکي کشور	تهران	1386
5	روش هاي تحقيق در علوم پزشكي	يکروزه	دانشگاه علوم پزشکي تبريز	تبريز	1386
6	بودجه ريزي عملياتي	دو روزه	وزارت كشور	تهران	1387
7	نرم افزارهاي اقتصادي	يکروزه	دانشگاه علوم پزشکي ايران	تهران	1386
8	مدل تعالي سازمان	دوره آموزشي غير حضوري	مركز آموزش و تحقيقات صنعتي ايران	تهران	1388
9	خلاقيت و نوآوري	دوره آموزشي غير حضوري	مركز آموزش و تحقيقات صنعتي ايران	تهران	1388
10	مديريت بحران	دوره آموزشي غير حضوري	مركز آموزش و تحقيقات صنعتي ايران	تهران	1388
11	کسب و کار در بازار جهاني	سمينار يکروزه	دانشگاه علوم پزشکي شهيد بهشتي	تهران	1388
12	آشنايي با مديريت مالي براي مديران غير مالي	دو روزه	دانشگاه علوم پزشکي شهيد بهشتي	تهران	1388
13	Current Challenge in Drug Development and Regulatory Affairs	سمينار يکروزه	دانشگاه علوم پزشکي شهيد بهشتي	تهران	1388
14	MCHE	مدرک زبان	وزارت علوم، تحقيقات و فناوري	تهران	1387
15	مجموعه کارگاههاي محوري توانمندسازي اساتيد	دوره ششماهه	دانشگاه علوم پزشکي تبريز-EDC	تبريز	1392
16	کارکاههاي زبان آکادميک	دوره چهارماهه	دانشگاه علوم پزشکي تبريز-EDC	تبريز	1392
17	کارگاه انديشه سياسي اسلام	دو روزه	دانشگاه علوم پزشکي تبريز-نهاد رهبري	تبريز	1392
18	کارکاه اصول اخلاق علمي	دو روزه	دانشگاه علوم پزشکي تبريز-نهاد رهبري	تبريز	1392
19	برنامه ريزي خطي در نظام سلامت	10 ساعت	قطب علمي مديريت سلامت و مرکز تحقيقات مديريت خدمات بهداشتي درماني	تبريز	1392
20	پژوهش عملياتي در نظام سلامت	10 ساعت	قطب علمي مديريت سلامت و مرکز تحقيقات مديريت خدمات بهداشتي درماني	تبريز	1392
21	Systematic review	10 ساعت	قطب علمي مديريت سلامت و مرکز تحقيقات مديريت خدمات بهداشتي درماني	تبريز	1393
22	کارگاه داده کاوي در نظام سلامت	10 ساعت	قطب علمي مديريت سلامت و مرکز تحقيقات مديريت خدمات بهداشتي درماني	تبريز	1393
23

طرح درس

اقتصاد بهداشت

مدیریت مالی

اقتصاد بهداشت - ارشد

روشهای پژوهش کمی

دانشکده مدیریت و اطلاع رسانی پزشکیSchool of management and medical informatics

دانشکده مدیریت و اطلاع رسانی پزشکی - علی ایمانی

علی ایمانی

درباره

کتاب ها

عنوان کتاب : مبانی ارزیابی های اقتصادی در سلامت

راهنمایی و مشاوره پایان نامه

اختراعات

مقالات ارائه شده

مقالات چاپ شده در مجلات

عنوان مقاله : Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran

عنوان مقاله : Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran

عنوان مقاله : Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran

عنوان مقاله : Affecting medical equipment maintenance management: A systematic review

عنوان مقاله : Cost-effectiveness analysis of biogeneric recombinant activated factor VII (AryoSeven™) and activated prothrombin complex concentrates (FEIBA™) to treat hemophilia a patients with inhibitors in Iran

عنوان مقاله : Identification of indicators for evaluating the financial and economic performance of the pharmacy: A systematic review

عنوان مقاله : Evaluation of factors affecting sales of prescription medicines by econometric methods in Iran

عنوان مقاله : Readiness for diet change and its association with diet knowledge and skills, diet decision making and diet barriers in type 2 diabetic patients

عنوان مقاله : Influential factors on medical equipment maintenance management: In search of a framework

عنوان مقاله : Studying international competitiveness in pharmaceutical sector in selected developed countries

عنوان مقاله : Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran

عنوان مقاله : Assessment of healthcare providers’ performance considering three healthcare quality indicators: A review article

عنوان مقاله : Challenges of implementing strategic purchasing of health services in Iran: A qualitative study Ali

عنوان مقاله : Comparison of bypassing agents in bleeding reduction in treatment of bleeding episodes in patients with haemophilia and inhibitors

عنوان مقاله : The relationship between pharmaceutical expenditures, health care expenditures and gross domestic product in Iran:1999-2008

برنامه درسی ترم جدید

سوابق اجرایی

علایق

کارگاه ها

طرح درس

تماس الکترونیکی